Latent Health is tapping into the $200 billion market for specialty drugs with AI agents that help doctors convince insurers to more quickly approve drugs and treatments people need.
In this week’s edition of InnovationRx, we look at Roche’s big AI drug development bet, an E. coli outbreak in raw milk cheddar, R1 Therapeutics’ $78 million raise, and more.
The Christmas Eve agreement—billed as Nvidia’s biggest deal in its three-decade history—landed at a precarious moment for Groq. Now Nvidia is betting on Groq’s inference-speed tech inside a newly announced chip platform.
One of the most popular ways to view the Epstein Files, an interface called Jmail that mimics a Gmail inbox, is hosted on Guillermo Rauch’s $9 billion unicorn Vercel.
An Israeli startup let its AI loose in advanced cyber games. It did better than 125,000 humans.
his week’s Current Climate newsletter also looks at Tesla’s best business bet and accelerating the shift from fossil fuels for stability and energy security
How a new startup plans to power satellites with lasers. A new class of ultrafast AI chips also uses lasers. And startup Axiomatic AI is building better AI models for science and engineering.
Crusoe, Developer Of Massive Stargate Data Center, Is Now Pouring Money Into Small Ones Too
Tesla’s robotaxi and humanoid-robot promises remain unproven businesses. Its energy division isn’t. And therein lies the company’s next bright idea.
In this week’s edition of InnovationRx, we look at the richest five healthcare billionaires, Lilly’s first big AI success, Science Corp.’s brain implants, and more.